Expression and recovery of biologically active recombinant Apolipoprotein AIMilano from transgenic safflower (Carthamus tinctorius) seeds |
| |
Authors: | Cory L Nykiforuk Yin Shen Elizabeth W Murray Joseph G Boothe David Busseuil Eric Rhéaume Jean‐Claude Tardif Alexandra Reid Maurice M Moloney |
| |
Institution: | 1. SemBioSys Genetics Inc, Calgary, AB, Canada;2. Montreal Heart Institute, Montreal, QC, Canada;3. MITACS Inc., York University, York Lanes, Toronto, ON, Canada |
| |
Abstract: | Apolipoprotein AI Milano (ApoAIMilano) was expressed as a fusion protein in transgenic safflower seeds. High levels of expression corresponding to 7 g of ApoAIMilano per kilogram of seed have been identified in a line selected for commercialization. The ApoAIMilano fusion protein was extracted from seed using an oilbody‐based process and matured in vitro prior to final purification. This yielded a Des‐1,2‐ApoAIMilano product which was confirmed by biochemical characterization including immunoreactivity against ApoAI antibodies, isoelectric point, N‐terminal sequencing and electrospray mass spectrometry. Purified Des‐1,2‐ApoAIMilano readily associated with dimyristoylphosphatidylcholine in clearance assays comparable to Human ApoAI. Its biological activity was assessed by cholesterol efflux assays using Des‐1,2‐ApoAIMilano:1‐palmitoyl‐2‐oleoyl phosphatidylcholine complexes in vitro and in vivo. This study has established that high levels of biologically functional ApoAIMilano can be produced using a plant‐based expression system. |
| |
Keywords: | Apolipoprotein AIMilano safflower recombinant protein atherosclerosis |
|
|